Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence
JH Hayes, MJ Barry - Jama, 2014 - jamanetwork.com
Importance Prostate cancer screening with the prostate-specific antigen (PSA) test remains
controversial. Objective To review evidence from randomized trials and related modeling …
controversial. Objective To review evidence from randomized trials and related modeling …
[HTML][HTML] Dietary factors and prostate cancer development, progression, and reduction
M Oczkowski, K Dziendzikowska… - Nutrients, 2021 - mdpi.com
Due to the constantly increasing number of cases, prostate cancer has become one of the
most important health problems of modern societies. This review presents the current …
most important health problems of modern societies. This review presents the current …
Early detection of prostate cancer: AUA Guideline
HB Carter, PC Albertsen, MJ Barry, R Etzioni… - The Journal of …, 2013 - auajournals.org
Purpose: The guideline purpose is to provide the urologist with a framework for the early
detection of prostate cancer in asymptomatic average risk men. Materials and Methods: A …
detection of prostate cancer in asymptomatic average risk men. Materials and Methods: A …
American Cancer Society prostate cancer survivorship care guidelines
TA Skolarus, AMD Wolf, NL Erb… - CA: a cancer journal …, 2014 - Wiley Online Library
Answer questions and earn CME/CNE Prostate cancer survivors approach 2.8 million in
number and represent 1 in 5 of all cancer survivors in the United States. While guidelines …
number and represent 1 in 5 of all cancer survivors in the United States. While guidelines …
Prostate cancer in young men: an important clinical entity
CA Salinas, A Tsodikov, M Ishak-Howard… - Nature Reviews …, 2014 - nature.com
Prostate cancer is considered a disease of older men (aged> 65 years), but today over 10%
of new diagnoses in the USA occur in young men aged≤ 55 years. Early-onset prostate …
of new diagnoses in the USA occur in young men aged≤ 55 years. Early-onset prostate …
Prevention of prostate cancer morbidity and mortality: primary prevention and early detection
MJ Barry, LH Simmons - Medical Clinics, 2017 - medical.theclinics.com
Disclosure: Dr MJ Barry is President of the Informed Medical Decisions Foundation, a part of
Healthwise, where he is also Chief Science Officer. Healthwise is a 501 (c) 3 nonprofit …
Healthwise, where he is also Chief Science Officer. Healthwise is a 501 (c) 3 nonprofit …
Validation of a genomic classifier that predicts metastasis following radical prostatectomy in an at risk patient population
RJ Karnes, EJ Bergstralh, E Davicioni… - The Journal of …, 2013 - auajournals.org
Purpose: Patients with locally advanced prostate cancer after radical prostatectomy are
candidates for secondary therapy. However, this higher risk population is heterogeneous …
candidates for secondary therapy. However, this higher risk population is heterogeneous …
[HTML][HTML] Global incidence of prostate cancer in developing and developed countries with changing age structures
To investigate the global incidence of prostate cancer with special attention to the changing
age structures. Data regarding the cancer incidence and population statistics were retrieved …
age structures. Data regarding the cancer incidence and population statistics were retrieved …
Trends in prostate cancer in the United States
OW Brawley - Journal of the National Cancer Institute …, 2012 - academic.oup.com
Abstract In the United States, prostate cancer is the most commonly diagnosed non–skin
cancer and the second leading cause of cancer death. The American Cancer Society …
cancer and the second leading cause of cancer death. The American Cancer Society …
Point-of-Care prostate specific antigen testing: examining translational progress toward clinical implementation
Prostate cancer (PCa) is the second most common male cancer and is attributable to over
375,000 deaths annually. Prostate specific antigen (PSA) is a key biomarker for PCa and …
375,000 deaths annually. Prostate specific antigen (PSA) is a key biomarker for PCa and …